Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey C Farrell

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Journal of Hepatology|May 5, 2004
Toxicity of low dose azathioprine and 6-mercaptopurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injuryMichael J Tapner, Brett E Jones, Wan M Wu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 28, 2018
Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitisLaurence Poekes, Justine Gillard, Geoffrey C Farrell, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in miceEmilia Ip, Geoffrey C Farrell, Graham Robertson, et al.
Journal of Hepatology|December 8, 2004
Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in miceIsabelle A Leclercq, Geoffrey C Farrell, Christine Sempoux, et al.
Hepatology Communications|September 24, 2021
Role of Cholesterol-Associated Steatohepatitis in the Development of NASHChristian L Horn, Amilcar L Morales, Christopher Savard, et al.
Expert Opinion on Pharmacotherapy|December 4, 2003
Pharmacotherapy of hepatocellular carcinomaJohn F Perry, Simone I Strasser, Jacob George, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Beyond insulin resistance in NASH: TNF-alpha or adiponectin?Jason M Hui, Alex Hodge, Geoffrey C Farrell, et al.
Journal of Hepatology|June 7, 2008
MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytesClaire Z Larter, Matthew M Yeh, Jacqueline Williams, et al.
Hepatology (Baltimore, Md.)|February 5, 2010
Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injuryNarci C Teoh, Jacqueline Williams, Jennifer Hartley, et al.
The American Journal of Gastroenterology|May 11, 2002
Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistanceJason M Hui, Jacob George, Christopher Liddle, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Journal of Hepatology|May 5, 2004
Toxicity of low dose azathioprine and 6-mercaptopurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injuryMichael J Tapner, Brett E Jones, Wan M Wu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 28, 2018
Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitisLaurence Poekes, Justine Gillard, Geoffrey C Farrell, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in miceEmilia Ip, Geoffrey C Farrell, Graham Robertson, et al.
Journal of Hepatology|December 8, 2004
Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in miceIsabelle A Leclercq, Geoffrey C Farrell, Christine Sempoux, et al.
Hepatology Communications|September 24, 2021
Role of Cholesterol-Associated Steatohepatitis in the Development of NASHChristian L Horn, Amilcar L Morales, Christopher Savard, et al.
Expert Opinion on Pharmacotherapy|December 4, 2003
Pharmacotherapy of hepatocellular carcinomaJohn F Perry, Simone I Strasser, Jacob George, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Beyond insulin resistance in NASH: TNF-alpha or adiponectin?Jason M Hui, Alex Hodge, Geoffrey C Farrell, et al.
Journal of Hepatology|June 7, 2008
MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytesClaire Z Larter, Matthew M Yeh, Jacqueline Williams, et al.
Hepatology (Baltimore, Md.)|February 5, 2010
Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injuryNarci C Teoh, Jacqueline Williams, Jennifer Hartley, et al.
The American Journal of Gastroenterology|May 11, 2002
Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistanceJason M Hui, Jacob George, Christopher Liddle, et al.
Pageof 13